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Lifetime self-reported arthritis is 
associated with elevated levels 
of mental health burden: A multi-
national cross sectional study across 
46 low- and middle-income countries
Brendon Stubbs1,2,4,9, Nicola Veronese3,4, Davy Vancampfort5,6, Trevor Thompson7, Cristiano 
Kohler8, Patricia Schofield9, Marco Solmi6,10, James Mugisha11,12, Kai G. Kahl13, Toby 
Pillinger1,2, Andre F. Carvalho14 & Ai Koyanagi15,16
Population-based studies investigating the relationship of arthritis with mental health outcomes are 
lacking, particularly among low- and middle-income countries (LMICs). We investigated the relationship 
between arthritis and mental health (depression spectrum, psychosis spectrum, anxiety, sleep 
disturbances and stress) across community-dwelling adults aged ≥18 years across 46 countries from the 
World Health Survey. Symptoms of psychosis and depression were established using questions from the 
Mental Health Composite International Diagnostic Interview. Severity of anxiety, sleep problems, and 
stress sensitivity over the preceding 30 days were self-reported. Self-report lifetime history of arthritis was 
collected, including presence or absence of symptoms suggestive of arthritis: pain, stiffness or swelling of 
joints over the preceding 12-months. Multivariable logistic regression analyses were undertaken. Overall, 
245,706 individuals were included. Having arthritis increased the odds of subclinical psychosis (OR = 1.85; 
95%CI = 1.72–1.99) and psychosis (OR = 2.48; 95%CI = 2.05–3.01). People with arthritis were at increased 
odds of subsyndromal depression (OR = 1.92; 95%CI = 1.64–2.26), a brief depressive episode (OR = 2.14; 
95%CI = 1.88–2.43) or depressive episode (OR = 2.43; 95%CI = 2.21–2.67). Arthritis was also associated 
with increased odds for anxiety (OR = 1.75; 95%CI = 1.63–1.88), sleep problems (OR = 2.23; 95%CI = 2.05–
2.43) and perceived stress (OR = 1.43; 95%CI = 1.33–1.53). Results were similar for middle-income and 
low-income countries. Integrated interventions addressing arthritis and mental health comorbidities are 
warranted to tackle this considerable burden.
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Recent global burden of disease surveys have demonstrated that chronic musculoskeletal and joint conditions are 
leading causes of disability, particularly in Western societies1, 2. One of the main clusters of chronic musculoskel-
etal and joint disorders is arthritis, a broad term encompassing osteoarthritis (OA) and inflammatory arthritic 
conditions such as rheumatoid arthritis (RA). The hallmark features of arthritis in both OA and RA are pain and 
discomfort. Unsurprisingly, an increasing body of evidence has demonstrated that OA3 and RA4 are associated 
with high levels of disability and lower quality of life5.
Recently, there is increasing interest in the mental health burden of arthritis. Specifically, Matcham et al.6 in 
a meta-analysis of 72 studies established that 38% of people with RA met the criteria for depression according to 
the Patient Health Questionnaire7 whilst 16.8% had major depressive disorder, figures considerably higher than 
the general population. The presence of anxiety and depression in RA is important since it is known to predict 
treatment response in patients with RA8. Stubbs et al.9 recently conducted a meta-analysis and established that 
one fifth of people with OA had anxiety or depression. A recent longitudinal study in North America demon-
strated that multisite OA is associated with an increased incidence of depression10. A number of single country 
studies have also demonstrated that RA11 and OA12 are associated with sleep disturbance. Sleep disturbance and 
perceived stress have also been demonstrated to be associated with worse outcomes in people with RA13. Thus, 
clearly, mental health symptoms are common and negatively impact the quality of life and treatment outcomes 
for people with arthritis.
Whilst progress has been made in understanding the mental health burden associated with arthritis, some 
pertinent limitations and gaps within the literature exist. First, to date, most studies considering arthritis and 
mental health have been based on clinical samples, and there is a lack of community-based studies. Moreover, 
there is a paucity of large representative multinational studies, particularly among low- and middle-income coun-
tries (LMICs). The majority of the world’s population resides in LMICs. A recent meta-analysis demonstrated 
that 3.16 million males and 14.87 million females were affected by RA in 2010 in LMICs with a rapid increase 
expected14. Resources to deal with the physical aspect of arthritis or mental health generally are not well estab-
lished nor a priority in LMICs. Therefore, this comorbidity may be particularly challenging in this setting, and 
understanding the mental health burden of arthritis is important for planning service development. Moreover, 
people in LMICs are more likely to undertake labor-demanding jobs in the informal sector with no job security 
or compensation for lost income. Therefore, maintaining good mental and physical health is crucial for their 
livelihoods and general welfare. Furthermore, it is possible, for example, that pain associated with arthritis could 
increase the mental health burden and stress in an environment where reliance on income from labor-demanding 
jobs is widespread. Therefore, there is a need to elucidate the potential mental health burden among people with 
arthritis in LMICs. Second, the majority of studies considering mental health comorbidity and arthritis have 
focused on common mental disorders such as depression or anxiety and very few studies have considered psy-
chosis for instance. However, there is an intriguing negative relationship that has been reported between schiz-
ophrenia and RA in Western counties15 and a paucity of data is available on arthritis and people with psychotic 
symptoms who do not meet the criteria for a diagnosis. In addition, there is increasing recognition that depres-
sion sits on a continuum with various subtypes, yet there is a lack of studies considering the relationship between 
arthritis and the depression continuum. Clearly, understanding a wider range of mental health comorbidities 
(including depression subtypes, psychosis, sleep disturbance, anxiety, and perceived stress) in arthritis important.
Given the aforementioned, the aim of the current study was to explore the relationship between arthritis and 
mental health (depression subtypes, psychosis, anxiety, sleep problems, and stress sensitivity). We hypothesized 
that people with arthritis in both low-income and middle-income countries would have worse mental health 
outcomes than those without arthritis.
Data and Methods
Procedures. The data for the current study was captured from the World Health Survey (WHS). The WHS 
was a cross-sectional study undertaken in 2002–2004 in 70 countries worldwide. Data were collected using 
single-stage random sampling and stratified multi-stage random cluster sampling across 10 and 60 countries 
respectively. Full details of the WHS are available elsewhere (http://www.who.int/healthinfo/survey/en/). In brief, 
persons aged ≥18 years with a valid home address were eligible to participate. Each member of the household 
had equal probability of being selected by utilizing Kish tables. A standardized questionnaire, translated accord-
ingly was used across all countries. Linguists ensured that the translation was conducted to a high standard. The 
individual response rate (i.e. ratio of completed interviews among selected respondents after excluding ineligible 
respondents from the denominator) ranged from 63% (Israel) to 99% (Philippines)16. Ethical approval to conduct 
this study was obtained from the ethical boards at each study site (see Appendix 1 for details of approving board 
at each study site) and in accordance with each sites regulations. Sampling weights were generated to adjust for 
non-response and the population distribution reported by the United Nations Statistical Division. Informed con-
sent was obtained from all participants.
Of the 70 countries, 69 had data which were publically available. Of these, 10 countries (Austria, Belgium, 
Denmark, Germany, Greece, Guatemala, Italy, Netherlands, Slovenia, and UK) were excluded due to lack of data 
on sampling information. Furthermore, 10 high-income countries (Finland, France, Ireland, Israel, Luxembourg, 
Norway, Portugal, Spain, Sweden, United Arab Emirates) were excluded in order to focus on LMICs. Of the 
remaining LMICs, Slovakia, Congo, and Swaziland were excluded as >25% of the data on arthritis was missing. 
Thus, the final sample consisted of 46 countries which corresponded to 20 low-income and 26 middle-income 
countries according to the World Bank classification at the time of the survey (2003).
www.nature.com/scientificreports/
3ScIentIFIc RepoRtS | 7: 7138 | DOI:10.1038/s41598-017-07688-6
Primary variables. Arthritis (exposure variable). Individuals with a self-reported lifetime diagnosis of 
arthritis and/or typical symptoms of arthritis were considered to have arthritis. The specific question used to 
assess a lifetime diagnosis was “Have you ever been diagnosed with arthritis (a disease of the joints)”?
We also used a symptom-based approach to minimize reporting bias especially in areas where access to med-
ical facilities is limited. The symptom-based algorithm was based on questions on typical clinical symptoms used 
in previous publications using the same questionnaire17, 18. Specifically, those who replied affirmatively to both of 
the following questions were considered to have arthritis: During the last 12 months, have you experienced: (a) 
pain, aching, stiffness or swelling in or around the joint (like arms, hands, legs or feet) which were not related to 
an injury and lasted for more than a month?; (b) stiffness in the joint in the morning after getting up from bed, or 
after a long rest of the joint without movement?
Mental health conditions (outcome variables). Depression type. The severity of depressive symptoms 
was established based on the individual questions of the World Mental Health Survey version of the Mental 
Health Composite International Diagnostic Interview (CIDI), which assessed the duration and persistence of 
depressive symptoms in the past 12 months19. Following the algorithms used in a previous WHS publication20, 
four mutually exclusive groups were established based on the ICD-10 Diagnostic Criteria for Research (ICD-
10-DCR) where criterion B referred to symptoms of depressed mood, loss of interest, and fatigability. The algo-
rithms used to define the four groups were the following: (a) Depressive episode group: At least two criterion B 
symptoms together with a total of at least four depressive symptoms lasting two weeks most of the day or all of 
the day. (b) Brief depressive episode group: Same criteria as depressive episode above but duration did not meet 
the two-week duration criterion. (c) Subsyndromal depression: At least one criterion B symptom together with 
the total number of symptoms being three or less. The criteria of duration of at least two weeks and presence of 
symptoms during most of the day had to be met. (d) No depressive disorder group: None of the above.
Psychosis. Participants were asked whether they had ever been diagnosed as having schizophrenia or psy-
chosis. All participants, regardless of a psychosis diagnosis, were asked questions on positive psychotic symptoms 
which came from the WHO Composite International Diagnostic Interview(CIDI) 3.019. This psychosis module 
has been reported to be highly consistent with clinician ratings with a kappa agreement coefficient of 0.82 for 
DSM-IV diagnosis of schizophrenia with even higher concordance observed for hallucinations and delusions21. 
Furthermore, psychotic experiences determined with the CIDI have been reported to be a good screening tool 
to identify those at high risk of developing psychosis22. The hallucinations question excluded conditions associ-
ated with sleep-related states or substance use. Specifically, respondents were asked the following questions with 
answer options ‘yes’ or ‘no’: During the last 12 months, have you experienced (i) ‘A feeling something strange and 
unexplainable was going on that other people would find hard to believe’? (delusional mood); (ii) ‘A feeling that 
people were too interested in you or there was a plot to harm you’? (delusions of reference and persecution); (iii) 
‘A feeling that your thoughts were being directly interfered or controlled by another person, or your mind was 
being taken over by strange forces’? (delusions of control); (iv) ‘An experience of seeing visions or hearing voices 
that others could not see or hear when you were not half asleep, dreaming or under the influence of alcohol or 
drugs’? (hallucinations).
Individuals who endorsed at least one of the four above-mentioned psychotic symptoms were consid-
ered to have psychotic symptoms. Based on information on psychosis diagnosis and psychotic symptoms, a 
three-category psychosis variable was constructed: (i) no psychosis diagnosis and no psychotic symptoms (con-
trol); (ii) at least one psychotic symptom but no psychosis diagnosis (subclinical psychosis); and (iii) psychosis 
diagnosis23, 24.
Sleep problems. Sleep problems were assessed by the question “Overall in the last 30 days, how much of a 
problem did you have with sleeping, such as falling asleep, waking up frequently during the night or waking up 
too early in the morning”? with answer options none, mild, moderate, severe, and extreme. Those who answered 
severe and extreme were considered to have sleep problems. This definition has been used in previous publica-
tions using the same survey question on sleep problems18, 25, 26.
Anxiety. Anxiety was assessed by the question “Overall in the past 30 days, how much of a problem did you 
have with worry or anxiety”? Respondents could answer: none, mild, moderate, severe, or extreme. In the current 
study those who answered severe and extreme were categorized as having anxiety26, 27.
Perceived stress. Perceived stress in the last month was assessed by two questions: “How often have you felt 
that you were unable to control the important things in your life”?; and “How often have you found that you could 
not cope with all the things that you had to do?” The answer options to these questions were: never (score = 1), 
almost never (score = 2), sometimes (score = 3), fairly often (score = 4), very often (score = 5). The scores of the 
two questions were added to create a scale ranging from 2 to 1028. The highest quintile (cut-off ≥7) was used to 
define a high level of perceived stress.
Other variables. Variables on sex, age, highest education achieved (no formal education, primary education, 
secondary or high school completed, or tertiary education completed), wealth, setting (rural or urban), smoking, 
alcohol consumption, angina, asthma, diabetes, and Body Mass Index (BMI) were considered as potential corre-
lates of arthritis based on past literature4, 29. Principal component analysis based on 15–20 assets was performed to 
establish country-wise wealth quintiles. The question on smoking was ‘Do you currently smoke any tobacco prod-
ucts such as cigarettes, cigars, or pipes’? with the answer options being ‘daily’, ‘yes, but not daily’, or ‘no, not at all’. 
This variable was dichotomized into those who smoked regardless of frequency (i.e. daily or not daily) (current 
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smokers) and those who do not smoke. Alcohol consumption was assessed by first asking the question ‘Have 
you ever consumed a drink that contains alcohol (such as beer, wine, etc.)’? Respondents who replied ‘no’ were 
considered lifetime abstainers. If the respondent replied affirmatively, then he/she was asked how many standard 
drinks of any alcoholic beverage he/she had on each day of the past 7 days. The number of days in the past week 
in which 4 (female) or 5 (male) drinks were consumed was calculated, and a total of 1–2 and >3 days in the past 
7 days were considered infrequent and frequent heavy drinking respectively. Those who have ever consumed 
alcohol but were neither an infrequent or frequent heavy drinker were considered to be non-heavy drinkers. A 
three-category variable was created: (a) lifetime abstainer or non-heavy drinker; (b) infrequent heavy drinker; 
and (c) frequent heavy drinker30. Asthma and diabetes were based solely on self-reported lifetime diagnosis. For 
angina, in addition to a self-reported diagnosis, a symptom-based diagnosis based on the Rose questionnaire was 
also used31. BMI was based on self-reported weight and height, and was calculated as weight in kilograms divided 
by height in meters squared. BMI was categorized as <18.5 (underweight), 18.5–24.9 (normal weight), 25.0–29.9 
(overweight), and ≥30 (obese) kg/m2 32.
Statistical analysis. The statistical analysis was performed with Stata 14.1 (Stata Corp LP, College station, 
Texas). The age- and sex-adjusted prevalence of arthritis for each country was estimated by using the United 
Nations population pyramids for the year 2010 (http://esa.un.org/wpp/Excel-Data/population.htm) as the 
standard population using age strata of 18–34, 35–59, and ≥60 years. The subsequent analyses used the overall 
sample including all countries or samples by country-income level (i.e. low-income or middle-income coun-
tries). Multivariable binary logistic regression analysis with arthritis as the outcome was performed to assess 
the correlates of arthritis. The correlates considered were sex, age, education, wealth, setting, smoking, alcohol 
consumption, angina, asthma, diabetes, and BMI. In order to assess the association between arthritis (exposure 
variable) and the mental health outcomes, multivariable binary and multinomial logistic regression analyses were 
conducted. Multinomial logistic regression analysis was conducted for psychosis and depression type, which 
consisted of more than two categories. When anxiety, sleep problems, and perceived stress were the outcome, 
binary logistic regression analysis was conducted. These analyses adjusted for all the potential correlates men-
tioned above as they have been reported to be associated with both arthritis and mental health outcomes12, 33–37. 
All variables were included in the models as categorical variables with the exception of age (continuous variable). 
All regression analyses were adjusted for country by including dummy variables for each country in the models, 
as in previous WHS publications38, 39. We did not use multilevel models as multilevel analyses with complex study 
designs can produce potentially biased estimates40. Turkey was not included in the regression analyses as it lacked 
data on education. Furthermore, due to completely missing data, the analysis with perceived stress as the outcome 
did not include Brazil, Hungary, and Zimbabwe, while Morocco was omitted from the analysis with anxiety as 
the outcome. The sample weighting and the complex study design were taken into account in all analyses with the 
use of the Stata svy command. Results from the logistic regression models are presented as odds ratios (ORs) with 
95% confidence intervals (CIs). The level of statistical significance was set at P < 0.05.
Less than 5% of the data was missing for all variables used in the analysis with the exception of education 
(8.1%), wealth (8.4%), alcohol consumption (5.2%), BMI (30.1%), diabetes (15.9%), and psychosis (15.8%). For 
the regression analyses, we conducted multiple imputation of missing values using the mi commands in Stata 
using chained equations (20 imputations)41. This method uses information from all other variables except the 
one being imputed to impute missing values. The variables included in the imputation model were the outcome 
and all other covariates42. A predictive mean matching algorithm was used for continuous variables, while for 
dichotomous and ordinal variables, binary logistic regression models and ordered logistic regression models, 
respectively, were used. The results based on complete case analysis were similar (Appendixs 2 and 3).
Results
A total of 245,706 individuals (LIC = 102,211 and MIC = 143,495) constituted the final analytical sample. Overall, 
there were more females than males (50.7% vs. 49.3%), and the mean (SD) age was 38.4 (16.0) years. The sample 
size of each country ranged from 929 (Latvia) to 38,746 (Mexico) (Table 1). The age- and sex-adjusted prevalence of 
arthritis in the overall sample was 22.4% (95%CI = 21.9%–22.8%) with the corresponding figures for low-income 
and middle-income countries being 23.4% (95%CI = 22.7%–24.1%) and 20.9 (95%CI = 20.4%–21.9%) 
respectively. This figure ranged from 7.2% (Myanmar) to 42.6% (Malawi) with high prevalence also being 
observed in Chad (40.6%), Morocco (34.7%), and India (32.4%) (Table 1, Fig. 1). The sample characteristics are 
shown in Table 2. In the overall sample, female sex, older age, lower education, poverty, rural setting, smoking, 
lower alcohol consumption, angina, asthma, diabetes, higher BMI, and all the mental health outcomes were more 
common among those with arthritis (Table 2).
The correlates of arthritis estimated by multivariable binary logistic regression are presented in Table 3. In the 
overall sample, female sex, older age, lower education, poverty, smoking, angina, asthma, diabetes, and higher 
BMI were associated with arthritis. Similar correlates were found in the samples stratified by country-income 
level although there were some differences. Specifically, wealth and BMI were not significantly associated with 
arthritis in low-income countries.
Mental health comorbidity and arthritis. The associations between arthritis and mental health outcomes 
estimated by multinomial and logistic regression are illustrated in Table 4. In the overall sample, after adjust-
ing for potential confounders, having arthritis increased the odds of having subclinical psychosis (OR = 1.85; 
95%CI = 1.72–1.99) or a psychosis diagnosis (OR = 2.48; 95%CI = 2.05–3.01) compared to no psychosis. The 
odds for all types of depression compared to no depression were also increased in those with arthritis: subsyn-
dromal depression (OR = 1.92; 95%CI = 1.64–2.26); brief depressive episode (OR = 2.14; 95%CI = 1.88–2.43); 
depressive episode (OR = 2.43; 95%CI = 2.21–2.67). Furthermore, arthritis was also associated with increased 
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odds for anxiety (OR = 1.75; 95%CI = 1.63–1.88); sleep problems (OR = 2.23; 95%CI = 2.05–2.43) and perceived 
stress (OR = 1.43; 95%CI = 1.33–1.53). The results for middle-income and low-income countries were similar.
Discussion
The current large scale study involving almost a quarter of a million people over 46 LMICs established that the 
age- and sex-adjusted prevalence of arthritis was 22.4% across all countries and 23.4% in low-income and 20.9% 
Country
Low-income countries Middle-income countries
Unweighted N % (SE) Country Unweighted N % (SE)
Bangladesh 5,942 24.0 (1.1) Bosnia Herzegovina 1,031 18.8 (1.8)
Burkina Faso 4,948 20.2 (1.4) Brazil 5,000 20.6 (0.7)
Chad 4,870 40.6 (1.4) China 3,994 14.2 (1.1)
Comoros 1,836 18.5 (1.4) Croatia 993 22.8 (1.4)
Ethiopia 5,089 31.2 (1.2) Czech Republic 949 24.0 (1.9)
Ghana 4,165 19.0 (0.8) Dominican Republic 5,027 20.1 (0.8)
India 10,687 32.4 (1.3) Ecuador 5,675 16.9 (0.9)
Ivory Coast 3,251 21.5 (1.2) Estonia 1,020 27.4 (1.7)
Kenya 4,640 15.4 (0.9) Georgia 2,950 23.0 (0.9)
Laos 4,988 12.9 (0.7) Hungary 1,419 30.1 (1.2)
Malawi 5,551 42.6 (1.1) Kazakhstan 4,499 21.7 (0.8)
Mali 4,886 19.9 (0.9) Latvia 929 24.2 (1.7)
Mauritania 3,902 28.4 (1.2) Malaysia 6,145 14.2 (0.5)
Myanmar 6,045 7.2 (0.6) Mauritius 3,968 15.2 (0.9)
Nepal 8,820 30.1 (0.6) Mexico 38,746 9.7 (0.3)
Pakistan 6,501 19.7 (0.8) Morocco 5,000 34.7 (1.1)
Senegal 3,461 27.3 (1.2) Namibia 4,379 15.5 (1.0)
Vietnam 4,174 9.4 (0.9) Paraguay 5,288 18.5 (0.6)
Zambia 4,165 9.0 (0.7) Philippines 10,083 27.3 (0.8)
Zimbabwe 4,290 11.8 (0.7) Russia 4,427 22.5 (1.2)
South Africa 2,629 20.9 (1.3)
Sri Lanka 6,805 14.7 (0.8)
Tunisia 5,202 30.9 (0.9)
Turkey 11,481 19.1 (0.7)
Ukraine 2,860 25.1 (1.3)
Uruguay 2,996 14.1 (0.5)
Table 1. Sample size and age- and sex-adjusted prevalence of arthritis by country. Abbreviation: SE standard 
error. All age- and sex-adjusted weighted estimates were calculated using the United Nations population 
pyramids for the year 2010.
Figure 1. Age- and sex-adjusted prevalence (%) of arthritis. Estimates were calculated using the United 
Nations population pyramids for the year 2010. The figure was created with STATA 13.1 (StataCorp. 2013. Stata 
Statistical Software: Release 13. College Station, TX: StataCorp LP).
www.nature.com/scientificreports/
6ScIentIFIc RepoRtS | 7: 7138 | DOI:10.1038/s41598-017-07688-6
in middle-income countries. In the overall sample, the correlates of arthritis estimated by multivariable logis-
tic regression included female sex, older age, lower education, poverty, smoking, angina, asthma, diabetes, and 
higher BMI. In LMICs collectively, we observed that people with arthritis were consistently more likely to have 
depression (all subtypes), subclinical psychosis, established psychotic disorder, sleep problems, anxiety, and 
higher levels of perceived stress. The increased mental health comorbidity among those with arthritis was con-
sistently raised in those in both low-income and middle-income countries.
Characteristic Category
Overall Low-income countries Middle-income countries
Total
Arthritis
Total
Arthritis
Total
Arthritis
No Yes No Yes No Yes
49.3 51.9 39.0 50.5 52.9 41.4 47.7 50.6 35.8
Female 50.7 48.1 61.0 49.5 47.1 58.6 52.3 49.4 64.2
Age (years) Mean 38.4 35.9 48.1 36.8 34.6 45.1 40.5 37.6 51.8
(SD) (16.0) (14.8) (16.8) (15.3) (14.1) (16.8) (16.6) (15.4) (16.4)
Educationa No formal 26.5 23.4 38.4 40.6 36.4 56.6 7.0 5.5 13.2
≤Primary 30.9 30.9 30.8 32.9 34.0 28.7 28.1 26.8 33.7
Secondary completed 33.4 36.0 23.4 20.5 22.8 11.5 51.2 54.2 39.7
Tertiary completed 9.2 9.6 7.5 6.0 6.8 3.1 13.6 13.5 13.5
Wealth Poorest 20.1 19.3 23.5 20.2 19.6 23.0 20.1 19.0 24.2
Poorer 20.1 19.4 22.7 20.0 19.2 22.8 20.1 19.6 22.5
Middle 20.0 20.0 20.0 19.9 19.8 20.0 20.2 20.3 20.1
Richer 19.8 20.4 17.6 20.0 20.5 18.0 19.7 20.3 17.3
Richest 20.0 20.9 16.2 20.0 20.9 16.2 19.9 20.9 16.1
Setting Rural 55.7 54.6 59.5 74.8 73.8 80.6 31.0 30.5 32.7
Urban 44.3 45.4 40.5 25.2 26.2 19.4 69.0 69.5 67.3
Smoking No 73.1 73.4 72.0 73.3 74.4 68.6 72.9 72.1 76.3
Yes 26.9 26.6 28.0 26.7 25.6 31.4 27.1 27.9 23.7
Alcohol Never/non-heavy 95.4 95.1 96.3 97.8 97.9 97.5 92.4 91.9 94.7
consumption Infrequent heavy 3.6 3.8 2.8 1.5 1.5 1.6 6.2 6.7 4.3
Frequent heavy 1.0 1.0 0.9 0.7 0.7 0.8 1.4 1.5 1.0
Angina No 85.7 90.5 66.8 85.2 89.7 67.5 86.3 91.4 65.9
Yes 14.3 9.5 33.2 14.8 10.3 32.5 13.7 8.6 34.1
Asthma No 94.9 95.9 91.1 95.9 97.0 91.8 93.7 94.6 90.2
Yes 5.1 4.1 8.9 4.1 3.0 8.2 6.3 5.4 9.8
Diabetes No 97.0 97.9 93.7 98.1 98.6 95.8 95.5 96.8 90.8
Yes 3.0 2.1 6.3 1.9 1.4 4.2 4.5 3.2 9.2
BMI (kg/m2) 18.5–24.9 57.6 59.3 50.5 62.1 63.1 57.7 53.3 55.6 43.9
25.0–29.9 19.8 19.2 22.6 11.5 11.2 13.0 27.9 27.0 31.6
≥30 9.1 8.0 13.7 6.1 5.7 7.7 12.0 10.3 19.2
<18.5 13.5 13.5 13.2 20.3 20.0 21.6 6.8 7.1 5.4
Psychosis Symptom (−) Diagnosis (−) 85.0 87.3 75.8 85.9 88.4 75.7 83.7 85.7 76.0
Symptom (+) Diagnosis (−) 13.9 11.9 21.8 12.9 10.7 21.6 15.4 13.6 22.1
Diagnosis (+) 1.1 0.8 2.3 1.2 0.9 2.7 0.9 0.6 1.9
Depression type No depression 88.4 91.3 75.6 88.3 91.3 74.5 88.5 91.2 77.1
Subsyndromal depression 2.4 1.9 4.8 3.0 2.3 6.2 1.6 1.3 2.8
Brief depressive episode 2.7 2.2 5.0 2.3 1.9 4.2 3.4 2.7 6.1
Depressive episode 6.5 4.6 14.6 6.4 4.5 15.1 6.6 4.8 13.9
Anxietyb No 88.4 90.6 79.8 90.9 93.2 82.2 85.2 87.4 76.6
Yes 11.6 9.4 20.2 9.1 6.8 17.8 14.8 12.6 23.4
Sleep problems No 92.3 94.9 81.8 93.0 95.4 83.7 91.3 94.3 79.3
Yes 7.7 5.1 18.2 7.0 4.6 16.3 8.7 5.7 20.7
Perceived stressc No 80.5 83.0 70.9 76.0 78.5 66.4 88.9 91.4 79.3
Yes 19.5 17.0 29.1 24.0 21.5 33.6 11.1 8.6 20.7
Table 2. Sample characteristics (overall and by country-income level and the presence of arthritis). 
Abbreviation: SD standard deviation; BMI body mass index. Data are % unless otherwise stated. All estimates 
are based on weighted sample. aTurkey is not included as it lacked information on education. bMorocco is not 
included as it lacked information on anxiety. cBrazil, Hungary, and Zimbabwe are not included as they lacked 
information on perceived stress.
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The prevalence of arthritis (22.3%) found in our LMIC sample was higher than a previous meta-analysis on 
the prevalence of RA which reported that 0.16% (95%CI: 0.11–0.20%) and 0.75% (95%CI: 0.60–0.90%) of males 
and females respectively had RA14. Moreover, this is also higher than the prevalence of OA reported in a recent 
global burden of disease survey of 3% and 5% in males and females respectively in Africa and central Asia29. 
However, a previous study using similar definitions of arthritis as in our study have found similarly high figures in 
9 LMICs, although the sample was limited to adults aged 50 years or older18. The potential reason for this might 
be the self-report questions used in the WHS in addition to a reflection in a potentially heightened prevalence of 
pain and stiffness among the sample.
In accordance with the literature in high-income countries6, 8–10, we observed heightened odds for all depres-
sion subtypes among those with arthritis versus controls. In many ways, the heightened mental health comor-
bidity among those with arthritis is unsurprising given the potential impact of pain, disability, and pressure to 
continue earning to provide an income for the family. It is interesting to note that all depression subtypes were 
associated with heightened odds with arthritis and to the best of our knowledge, our paper is the first multina-
tional paper to consider this relationship. This in contrast to recent work among people with back pain in LMICs, 
where an incremental increased odds of depression was noted with more severe depression subtypes43. It is also 
perhaps of little surprise that people with arthritis were more likely to have anxiety, sleep disturbances, and per-
ceived stress. These relationships may potentially be explained by increased levels of pain associated with arthritis. 
Specifically, the underlying shared pathophysiology of pain and depression could account for this, since both 
depression and pain facilitate modulation in the periaqueductal gray, amygdala, and hypothalamus regions44, 45. 
Second, arthritis46, pain, and depression47 are associated with and exacerbated by low levels of physical activity 
Characteristic
Overall Low-income countries
Middle-income 
countries
OR 95%CI OR 95%CI OR 95%CI
Sex
 Male 1.00 1.00 1.00
 Female 1.58*** [1.50,1.67] 1.56*** [1.45,1.69] 1.62*** [1.51,1.74]
Age (years) 1.04*** [1.04,1.04] 1.04*** [1.04,1.04] 1.04*** [1.04,1.05]
Education
 No formal 1.00 1.00 1.00
 ≤Primary 0.95 [0.88,1.01] 0.94 [0.86,1.02] 0.95 [0.84,1.07]
 Secondary completed 0.75*** [0.69,0.82] 0.71*** [0.63,0.80] 0.82** [0.72,0.94]
 Tertiary completed 0.69*** [0.62,0.78] 0.62*** [0.51,0.76] 0.78** [0.66,0.92]
Wealth
 Poorest 1.00 1.00 1.00
 Poorer 1.04 [0.97,1.13] 1.08 [0.97,1.20] 0.98 [0.88,1.08]
 Middle 0.97 [0.90,1.05] 0.98 [0.88,1.09] 0.94 [0.85,1.04]
 Richer 0.90* [0.82,0.98] 0.92 [0.81,1.04] 0.86** [0.76,0.96]
 Richest 0.86** [0.78,0.95] 0.88 [0.76,1.01] 0.84** [0.74,0.95]
Setting
 Rural 1.00 1.00 1.00
 Urban 0.94 [0.87,1.01] 0.93 [0.82,1.05] 0.95 [0.87,1.04]
Smoking
 No 1.00 1.00 1.00
 Yes 1.16*** [1.08,1.23] 1.17** [1.07,1.29] 1.16*** [1.07,1.26]
Alcohol consumption
 Never/non-heavy 1.00 1.00 1.00
 Infrequent heavy 1.01 [0.89,1.16] 1.26 [0.97,1.64] 0.94 [0.81,1.09]
 Frequent heavy 0.96 [0.77,1.20] 1.17 [0.88,1.55] 0.82 [0.59,1.15]
Angina 2.90*** [2.71,3.10] 2.86*** [2.59,3.15] 2.92*** [2.69,3.17]
Asthma 1.49*** [1.34,1.66] 1.49*** [1.28,1.75] 1.50*** [1.31,1.73]
Diabetes 1.58*** [1.38,1.82] 1.85*** [1.45,2.36] 1.39*** [1.18,1.64]
BMI (kg/m2)
 18.5–24.9 1.00 1.00 1.00
 25.0–29.9 1.12** [1.05,1.21] 1.06 [0.95,1.19] 1.21*** [1.11,1.32]
 ≥30.0 1.34*** [1.20,1.50] 1.17 [0.97,1.42] 1.56*** [1.39,1.74]
 <18.5 0.99 [0.91,1.08] 0.97 [0.87,1.08] 1.02 [0.89,1.16]
Table 3. Correlates of arthritis assessed by multivariable binary logistic regression analysis. Abbreviation: OR 
odds ratio; CI confidence interval; BMI Body mass index. The models are adjusted for all variables in the table 
and country. Turkey is not included in the regression analyses as it lacked information on education. *p < 0.05, 
**p < 0.01, ***p < 0.001.
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and social isolation48, 49. Thus, it is possible that these factors, which were not assessed in the current study, are 
implicated in the link between arthritis and worse mental health. Increasing physical activity has established effi-
cacy in reducing both depression50, 51 and pain as well as their associated disability52 and could therefore be key 
to reducing the burden of this comorbidity and improving function. Finally, within the context of some LMICs, 
the high prevalence of HIV and tuberculosis53 may account for both the depression54 and pain associated with 
arthritis55.
The increased odds of arthritis among people with a diagnosis of psychosis has to the best of our knowl-
edge not been previously reported in LMICs, and data on the relation between subclinical psychosis and arthri-
tis is scarce. Furthermore, very few community-based multinational studies exist on these associations even in 
high-income countries. Our finding that arthritis is associated with higher odds for psychotic disorders (e.g. 
schizophrenia) is in contrast to the trend that has previously been reported. A recent meta-analysis with poly-
genic risk score analysis found that people with schizophrenia are at reduced odds of RA, although this does not 
appear to be related to polygenic risk scores and may be more related to environmental risk factors such as the 
anti-inflammatory effects of antipsychotic medication56. A nationally representative study in Taiwan found that 
people with schizophrenia were not more likely than controls to develop OA (HR = 0.89; 95%CI = 0.81–1.01), 
p = 0.53)57. Thus, it appears that people with psychosis in LMICs may be more likely to have arthritis compared 
to their high-income counterparts. The precise reasons for this are unclear and future studies are warranted to 
assess whether our results may be replicated. RA aside, there is evidence that any history of autoimmune disease 
(including psoriasis, which can have a significant joint component) can increase the odds of developing schiz-
ophrenia58. In terms of the heightened odds for subclinical psychosis in arthritis, this may be explained by the 
psychological distress caused by the symptoms of arthritis (e.g. pain) which has been associated with psychotic 
symptoms in the general population30, 59, 60.
It is established from studies conducted in high-income countries that comorbid mental health outcomes 
among those with arthritis are associated with worse pain and poorer treatment outcomes8, 10, 61. Thus clearly 
integrated mental and physical healthcare is essential. However, in the context of arthritis, there is a paucity of 
evidence-based literature, in particular intervention studies. Regardless, the current data have important public 
health implications, particularly since the data were multi-national, population-based, and predominantly nation-
ally representative, rather than most literature to date which is derived from clinical samples. Understanding and 
treating comorbid mental health outcomes among those with arthritis is essential. An important environmental 
barrier in the care of people with mental and physical health problems in LMICs is the lack of integrated mental 
and physical healthcare services and the poorly developed community-based psychiatric services62. Closer inte-
gration of primary and mental health care in these countries is needed, but without obscuring the responsibility 
for arthritis and mental health assessment, prevention and management63. We suggest that people with arthritis 
are assessed for the mental health conditions assessed in our study (i.e., depression, anxiety, sleep disturbance, 
stress and psychosis) so that appropriate interventions can be provided. More research is required to understand 
the mental health burden of arthritis in LMICs and context-specific trials and evaluations in LMICs therefore are 
urgently needed.
Outcome
Overall Low-income countries
Middle-income 
countries
OR 95%CI OR 95%CI OR 95%CI
Multinomial logistic regression
Psychosis
  Symptom (−) Diagnosis 
(−) 1.00 1.00 1.00
  Symptom (+) Diagnosis 
(−) 1.85*** [1.72,1.99] 1.77*** [1.59,1.97] 1.98*** [1.79,2.18]
  Diagnosis (+) 2.48*** [2.05,3.01] 2.27*** [1.77,2.91] 2.98*** [2.24,3.97]
Depression type
  No depression 1.00 1.00 1.00
  Subsyndromal depression 1.92*** [1.64,2.26] 1.89*** [1.55,2.30] 2.06*** [1.59,2.67]
  Brief depressive episode 2.14*** [1.88,2.43] 2.09*** [1.75,2.49] 2.23*** [1.86,2.68]
  Depressive episode 2.43*** [2.21,2.67] 2.39*** [2.10,2.73] 2.51*** [2.21,2.83]
Binary logistic regression
  Anxietya 1.75*** [1.63,1.88] 1.69*** [1.53,1.86] 1.84*** [1.65,2.05]
  Sleep problems 2.23*** [2.05,2.43] 2.25*** [1.99,2.55] 2.21*** [1.98,2.47]
  Perceived stressb 1.43*** [1.33,1.53] 1.40*** [1.28,1.52] 1.49*** [1.35,1.65]
Table 4. The association between arthritis and mental health outcomes estimated by multinomial and binary 
logistic regression. Abbreviation: OR odds ratio; CI confidence interval. All models are adjusted for sex, age, 
education, wealth, setting, smoking, alcohol consumption, angina, asthma, diabetes, BMI, and country. Turkey 
is not included in the regression analyses as it lacked information on education. aMorocco is not included as it 
lacked information on anxiety. bBrazil, Hungary, and Zimbabwe are not included as they lacked information on 
perceived stress. ***p < 0.001.
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Some study design limitations need to be considered. First, the categorization of arthritis was based on 
self-report and it was not possible to explore in more detail the type, nature, and severity of arthritis. In par-
ticular, it was not possible to differentiate between OA and RA and other forms of arthritis. Thus, clearly, future 
research is required to disentangle the nature and mental health impact of the different forms of arthritis in 
LMICs. Second, the study sample only included non-institutionalized individuals. Thus, those with severe mental 
disorders or arthritis could have been omitted from the sample, leading to an underestimate of the associations. 
Next, we adjusted for a variety of potential confounders but we cannot preclude the possibility of residual con-
founding. For example, we were only able to adjust for a limited number of physical comorbidities. Finally, the 
data is cross-sectional thus it is not possible to disentangle the directionality of the relationships observed. It is 
important that future research attempts to understand the underlying explanatory factors of the relationships we 
observed. In particular, research considering psychotic disorders and RA are required among LMICs.
In conclusion, our large community-based study has demonstrated that arthritis is associated with a broad 
range of elevated mental health comorbidity. For the first time we demonstrated on a multinational scale that 
depression subtypes, psychosis spectrum, stress sensitivity and anxiety are increased in those with arthritis. 
Future longitudinal research is required to elucidate the course, trajectory, and outcomes of comorbid mental 
health and arthritis in LMICs.
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